Analyst Research Report Snapshot

Title:

PLETHORA SOLUTIONS HOLDINGS - STAYING THE COURSE

Price:

$10.00

Provider:

Edison Investment Research

Date:

17 Jul 2007

Pages:

12

Type:

AcrobatPDF

Companies referenced:

PLE.L

Available for Immediate Download
Summary:

Although the investment proposition for Plethora Solutions largely depends on the market for treating premature ejaculation (PE), its current market valuation barely seems to reflect even the most pessimistic scenario. Plethora’s relatively risk-averse development approach, portfolio of late-stage products for male sexual dysfunction, broader urology/women’s health pipeline and strategy to market and co-promote two lead projects all suggest a significant upside in the current share price. FOR MORE INFORMATION ON ATTACHED RESEARCH PLEASE CALL 020 7190 1755 OR EMAIL RESEARCH@EDISONINVESTMENTRESEARCH.CO.UK OR VISIT WWW.EDISONINVESTMENTRESEARCH.CO.UK

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.